Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
American Journal of Cancer Research
|
December 10, 2019
Akt inhibition at the initial stage of CAR-T preparation enhances the CAR-positive expression rate, memory phenotype and in vivo efficacy
Qing Zhang, Jiage Ding, Shishuo Sun, et al.
Cancer Immunology, Immunotherapy : CII
|
May 8, 2026
Novel recombinant protein PK5-Gal-3C enhances the anti-tumor activity of T cells via binding with TRPV2
Guopeng Zhang, Wei Zhang, Xiaohuan Wei, et al.
Frontiers in Oncology
|
May 6, 2021
Tyrosine Kinase Inhibitor Cabozantinib Inhibits Murine Renal Cancer by Activating Innate and Adaptive Immunity
Hongyan Liu, Shishuo Sun, Gang Wang, et al.
Biochemical and Biophysical Research Communications
|
October 5, 2024
Cabozantinib enhances CAIX specific CAR-T cells against renal cancer by improving effector functions and augmenting tumor immune microenvironment
Qihong Li, Lin Yang, Shuyu Li, et al.
Cancer Letters
|
November 28, 2023
PA suppresses antitumor immunity of T cells by disturbing mitochondrial activity through Akt/mTOR-mediated Ca<sup>2+</sup> flux
Shishuo Sun, Heng Xu, Wanxin Zhao, et al.
Cellular Immunology
|
January 22, 2022
CD36 regulates LPS-induced acute lung injury by promoting macrophages M1 polarization
Shishuo Sun, Yizhou Yao, Chao Huang, et al.
Ebiomedicine
|
February 11, 2019
Fatty acid 2-hydroxylation inhibits tumor growth and increases sensitivity to cisplatin in gastric cancer
Yizhou Yao, Xiaoqin Yang, Liang Sun, et al.
Cancer Immunology Research
|
January 23, 2023
Herpes Virus Entry Mediator Costimulation Signaling Enhances CAR T-cell Efficacy Against Solid Tumors Through Metabolic Reprogramming
Shishuo Sun, Chao Huang, Mengmeng Lu, et al.
Pharmacological Research
|
August 19, 2021
Lenvatinib enhances T cell immunity and the efficacy of adoptive chimeric antigen receptor-modified T cells by decreasing myeloid-derived suppressor cells in cancer
Mengmeng Lu, Xiaokang Zhang, Xiaoge Gao, et al.
Journal of Cancer Research and Clinical Oncology
|
August 12, 2022
Docetaxel enhances the therapeutic efficacy of PSMA-specific CAR-T cells against prostate cancer models by suppressing MDSCs
Xiaokang Zhang, Shishuo Sun, Yangna Miao, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
American Journal of Cancer Research
|
December 10, 2019
Akt inhibition at the initial stage of CAR-T preparation enhances the CAR-positive expression rate, memory phenotype and in vivo efficacy
Qing Zhang, Jiage Ding, Shishuo Sun, et al.
Cancer Immunology, Immunotherapy : CII
|
May 8, 2026
Novel recombinant protein PK5-Gal-3C enhances the anti-tumor activity of T cells via binding with TRPV2
Guopeng Zhang, Wei Zhang, Xiaohuan Wei, et al.
Frontiers in Oncology
|
May 6, 2021
Tyrosine Kinase Inhibitor Cabozantinib Inhibits Murine Renal Cancer by Activating Innate and Adaptive Immunity
Hongyan Liu, Shishuo Sun, Gang Wang, et al.
Biochemical and Biophysical Research Communications
|
October 5, 2024
Cabozantinib enhances CAIX specific CAR-T cells against renal cancer by improving effector functions and augmenting tumor immune microenvironment
Qihong Li, Lin Yang, Shuyu Li, et al.
Cancer Letters
|
November 28, 2023
PA suppresses antitumor immunity of T cells by disturbing mitochondrial activity through Akt/mTOR-mediated Ca<sup>2+</sup> flux
Shishuo Sun, Heng Xu, Wanxin Zhao, et al.
Cellular Immunology
|
January 22, 2022
CD36 regulates LPS-induced acute lung injury by promoting macrophages M1 polarization
Shishuo Sun, Yizhou Yao, Chao Huang, et al.
Ebiomedicine
|
February 11, 2019
Fatty acid 2-hydroxylation inhibits tumor growth and increases sensitivity to cisplatin in gastric cancer
Yizhou Yao, Xiaoqin Yang, Liang Sun, et al.
Cancer Immunology Research
|
January 23, 2023
Herpes Virus Entry Mediator Costimulation Signaling Enhances CAR T-cell Efficacy Against Solid Tumors Through Metabolic Reprogramming
Shishuo Sun, Chao Huang, Mengmeng Lu, et al.
Pharmacological Research
|
August 19, 2021
Lenvatinib enhances T cell immunity and the efficacy of adoptive chimeric antigen receptor-modified T cells by decreasing myeloid-derived suppressor cells in cancer
Mengmeng Lu, Xiaokang Zhang, Xiaoge Gao, et al.
Journal of Cancer Research and Clinical Oncology
|
August 12, 2022
Docetaxel enhances the therapeutic efficacy of PSMA-specific CAR-T cells against prostate cancer models by suppressing MDSCs
Xiaokang Zhang, Shishuo Sun, Yangna Miao, et al.
Page
of 3